Compound information
- Natural Products
- ZC402204
- Molecular Formula
- C10H9N3O2
- Molecular Weight
- 203.069476528 g/mol
- Structure
-
- IUPAC Name
- N-(2,1,3-benzoxadiazol-5-ylmethyl)prop-2-enamide
- InChI
- InChI=1S/C10H9N3O2/c1-2-10(14)11-6-7-3-4-8-9(5-7)13-15-12-8/h2-5H,1,6H2,(H,11,14)
- InChI Key
- KHCBBZXSLXNXCT-UHFFFAOYSA-N
- SMILES
- C=CC(=O)NCc1ccc2nonc2c1
- Source
- ZINC001356522737
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 15 | Ring Count | 2 |
Heteroatom Count | 5 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 68.02 Å2 | LogP | 1.566 |
LogS | -2.97 | LogD | 1.268 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.015 | Pgp substrate | 0.11 |
HIA | 0.961 | F20 % | 0.992 |
F30 % | 0.252 | Caco-2 | -4.467 |
MDCK | -4.707 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.996 | PPB | 90.442 |
VD | 0.769 | Fu | 0.467 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.993 | CYP1A2 substrate | 0.751 |
CYP2A6 substrate | 0.631 | CYP2B6 substrate | 0.561 |
CYP2C19 inhibitor | 0.416 | CYP2C19 substrate | 0.756 |
CYP2C8 substrate | 0.441 | CYP2C9 inhibitor | 0.04 |
CYP2C9 substrate | 0.27 | CYP2D6 inhibitor | 0.002 |
CYP2D6 substrate | 0.706 | CYP2E1 substrate | 0.461 |
CYP3A4 inhibitor | 0.008 | CYP3A4 substrate | 0.832 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.679 | CL | 7.278 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.356 | Hepatotoxicity | 0.847 |
Mutagenicity | 0.021 | Rat Oral Acute Toxicity | 0.198 |
FDAMDD | 0.658 | Skin Sensitization | 0.592 |
Carcinogenicity | 0.025 | Eye Corrosion | 0.008 |
Eye Irritation | 0.914 | Respiratory Toxicity | 0.966 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.875 | IGC50 | 3.165 |
LC50FM | 3.252 | LC50DM | 4.224 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.092 | NR-AR-LBD | 0.456 |
NR-AhR | 0.043 | NR-Aromatase | 0.036 |
NR-ER | 0.323 | NR-ER-LBD | 0.3 |
NR-PPAR-gamma | 0.758 | SR-ARE | 0.702 |
SR-ATAD5 | 0.649 | SR-HSE | 0.096 |
SR-MMP | 0.008 | SR-p53 | 0.084 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.